Xenetic Biosciences, Inc. (XBIO)

Last Closing Price: 1.53 (2026-11-18)

EBIT (Quarterly)

EBIT: Income before interest and taxes.

Xenetic Biosciences, Inc. (XBIO) had EBIT of $-1.74M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$0.73M
$-1.70M
--
$0.73M
$2.46M
$-1.74M
$0.04M
$-1.70M
$-1.70M
$-1.70M
$-1.70M
$-1.70M
$-1.70M
EBIT
$-1.74M
$-1.74M
2.34M
2.34M
$-0.72
$-0.72
Balance Sheet Financials
$6.00M
--
$0.31M
$6.32M
$1.90M
--
--
$1.90M
$4.41M
$4.41M
$4.41M
2.34M
Cash Flow Statement Financials
$-2.07M
--
--
$7.88M
$5.81M
$-2.07M
$0.10M
--
--
Fundamental Metrics & Ratios
3.15
--
--
--
--
100.00%
-239.80%
-239.80%
--
-233.78%
-233.78%
$-2.07M
--
--
--
0.11
--
--
--
-38.41%
-38.42%
-26.84%
-38.42%
$1.88
$-0.89
$-0.89